Personal tools

MCL coexpression mm9:3333: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002384!8.77e-13!46;UBERON:0002370!2.59e-11!23;UBERON:0000974!2.59e-11!23;UBERON:0004807!2.59e-11!23;UBERON:0005058!2.59e-11!23;UBERON:0003351!2.59e-11!23;UBERON:0009113!2.59e-11!23;UBERON:0003295!2.59e-11!23;UBERON:0009722!2.59e-11!23;UBERON:0005562!2.59e-11!23;UBERON:0007690!2.59e-11!23;UBERON:0002193!2.97e-11!48;UBERON:0002405!2.97e-11!48;UBERON:0006562!9.04e-11!24;UBERON:0003408!9.04e-11!24;UBERON:0001557!9.04e-11!24;UBERON:0001042!9.04e-11!24;UBERON:0008814!9.04e-11!24;UBERON:0009145!9.04e-11!24;UBERON:0002390!1.61e-10!45;UBERON:0003061!1.61e-10!45;UBERON:0004177!1.63e-10!29;UBERON:0005057!1.63e-10!29;UBERON:0000072!2.21e-09!27;UBERON:0000077!2.26e-08!35;UBERON:0007811!4.46e-08!36;UBERON:0000063!7.55e-07!35
|ontology_enrichment_uberon=UBERON:0002384!8.77e-13!46;UBERON:0002370!2.59e-11!23;UBERON:0000974!2.59e-11!23;UBERON:0004807!2.59e-11!23;UBERON:0005058!2.59e-11!23;UBERON:0003351!2.59e-11!23;UBERON:0009113!2.59e-11!23;UBERON:0003295!2.59e-11!23;UBERON:0009722!2.59e-11!23;UBERON:0005562!2.59e-11!23;UBERON:0007690!2.59e-11!23;UBERON:0002193!2.97e-11!48;UBERON:0002405!2.97e-11!48;UBERON:0006562!9.04e-11!24;UBERON:0003408!9.04e-11!24;UBERON:0001557!9.04e-11!24;UBERON:0001042!9.04e-11!24;UBERON:0008814!9.04e-11!24;UBERON:0009145!9.04e-11!24;UBERON:0002390!1.61e-10!45;UBERON:0003061!1.61e-10!45;UBERON:0004177!1.63e-10!29;UBERON:0005057!1.63e-10!29;UBERON:0000072!2.21e-09!27;UBERON:0000077!2.26e-08!35;UBERON:0007811!4.46e-08!36;UBERON:0000063!7.55e-07!35
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,1.43553,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.756749,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,0.444545,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.724277,0.610669,0.156582,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.777706,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,0.181575,0.568545,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.609576,0.805461,1.14346,1.37508,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.751419,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.999018,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.833542
}}
}}

Revision as of 22:45, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr2:173100994..173101005,+p@chr2:173100994..173101005
+
Mm9::chr7:133613706..133613730,-p@chr7:133613706..133613730
-
Mm9::chr7:4626140..4626153,-p@chr7:4626140..4626153
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
mature alpha-beta T cell1.78e-219
alpha-beta T cell1.78e-219
immature T cell1.78e-219
mature T cell1.78e-219
immature alpha-beta T cell1.78e-219
lymphoid lineage restricted progenitor cell5.03e-2012
hematopoietic cell9.39e-2032
hematopoietic oligopotent progenitor cell9.39e-2032
hematopoietic stem cell9.39e-2032
angioblastic mesenchymal cell9.39e-2032
hematopoietic multipotent progenitor cell9.39e-2032
lymphocyte2.29e-1813
common lymphoid progenitor2.29e-1813
CD4-positive, alpha-beta T cell2.55e-188
T cell2.38e-1711
pro-T cell2.38e-1711
nucleate cell1.23e-1416
leukocyte1.10e-1317
nongranular leukocyte1.10e-1317
connective tissue cell8.77e-1346
mesenchymal cell8.77e-1346
thymocyte1.15e-126
double negative thymocyte1.15e-126
naive T cell1.15e-126
double-positive, alpha-beta thymocyte1.15e-126
CD4-positive, alpha-beta thymocyte1.15e-126
naive thymus-derived CD4-positive, alpha-beta T cell1.15e-126
DN4 thymocyte1.15e-126
DN1 thymic pro-T cell1.15e-126
DN2 thymocyte1.15e-126
DN3 thymocyte1.15e-126
immature single positive thymocyte1.15e-126
early T lineage precursor1.15e-126
mature CD4 single-positive thymocyte1.15e-126
resting double-positive thymocyte1.15e-126
double-positive blast1.15e-126
CD69-positive double-positive thymocyte1.15e-126
CD69-positive, CD4-positive single-positive thymocyte1.15e-126
CD4-positive, CD8-intermediate double-positive thymocyte1.15e-126
CD24-positive, CD4 single-positive thymocyte1.15e-126
motile cell6.25e-1254
hematopoietic lineage restricted progenitor cell6.29e-1125
stem cell3.01e-0897

Uber Anatomy
Ontology termp-valuen
connective tissue8.77e-1346
thymus2.59e-1123
neck2.59e-1123
respiratory system epithelium2.59e-1123
hemolymphoid system gland2.59e-1123
pharyngeal epithelium2.59e-1123
thymic region2.59e-1123
pharyngeal gland2.59e-1123
entire pharyngeal arch endoderm2.59e-1123
thymus primordium2.59e-1123
early pharyngeal endoderm2.59e-1123
hemolymphoid system2.97e-1148
immune system2.97e-1148
pharynx9.04e-1124
gland of gut9.04e-1124
upper respiratory tract9.04e-1124
chordate pharynx9.04e-1124
pharyngeal arch system9.04e-1124
pharyngeal region of foregut9.04e-1124
hematopoietic system1.61e-1045
blood island1.61e-1045
hemopoietic organ1.63e-1029
immune organ1.63e-1029
segment of respiratory tract2.21e-0927
mixed endoderm/mesoderm-derived structure2.26e-0835
craniocervical region4.46e-0836
organ segment7.55e-0735


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}